Elacestrant in Preoperative Setting, a Window of Opportunity Study

Clinical trial NCT04797728 · COMPLETED

Trial details

NCT number: NCT04797728
Sponsor: SOLTI Breast Cancer Research Group
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Hormone Receptor Positive Breast Carcinoma

Start date: 2021-02-09
Primary completion: 2022-02-08
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.